S&P Futures
3,902.00 +4.25 (+0.11%) Dow Futures
31,241.00 +39.00 (+0.12%) Nasdaq Futures
11,838.00 -40.25 (-0.34%) Russell 2000 Futures
1,771.50 -3.40 (-0.19%) Crude Oil
110.35 +0.46 (+0.42%) Gold
1,845.10 +3.90 (+0.21%)
LivaNova PLC (LIVN)
After hours:
- Simply Wall St.
LivaNova's (NASDAQ:LIVN) Returns On Capital Not Reflecting Well On The Business
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
- American City Business Journals
ALung acquired by London-based health care company
ALung Technologies Inc., whose HemoLung product developed out of the University of Pittsburgh helps patients with acute respiratory distress, has been acquired by a London-based medical technology company. LivaNova (NASDAQ: LIVN) acquired ALung for $10 million with additional payments on sales-based milestones in the future, according to LivaNova's first-quarter earnings report that was released Wednesday. "ALung products are complementary to LivaNova's ACS portfolio and, as such, the business and financial results will be included in the company's ACS (Advanced Circulatory Support) segment," LivaNova said.
- Zacks
LivaNova (LIVN) Lags Q1 Earnings Estimates
LivaNova (LIVN) delivered earnings and revenue surprises of -7.69% and 3.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
